Barclays Explains Its Bullish Call On Myriad Genetics
July 05, 2016 at 10:59 AM EDT
Barclays provided its analysis of Myriad Genetics, Inc. (NASDAQ: MYGN) in a note published Tuesday, in which the analysts outlined both ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.